In ex vivo severe asthma bronchial biopsies, the protein levels were upregulated 1.2-fold for PHLDB2 (p = 0.2844), 2.4-fold (p < 0.01) for NEK6, and 2.0-fold for SCNN1G (p < 0.05). Here, PHLDB2 is linked to asthma.